How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer
- Susan F. Dent(corresponding author),
- Heather Moore,
- Priyanka Raval,
- Laura Alder,
- Duke University,
- ,
Scholary Output:
Contribution to journal
Review article
Peer-review
Open access
Sustainable Development Goals
SDG 3 Good Health and Well
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 404-408 (5 pages)Journal (Volume, Issue Number)
JACC: CardioOncology (Volume 4, Issue 3)Publication milestones
- Published - 09/2022
Publication status
Published - 09/2022
Publication IDs
- Scopus: 85137754210
Publication metrics
Metrics
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Captures
28
Citation count
13
Funding Details
Dr Guha is supported by the American Heart Association Strategically Focused Research Network Grant in Disparities in Cardio-Oncology (847740 and 863620). Dr Dent has received research funding and honoraria from Novartis; and is a consultant for AstraZeneca; Dr Moore is a consultant for Novartis, Daiichi Sankyo, AstraZeneca, SeaGen, and Eli Lilly. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
FunderFunding numbers
AHA
847740, 863620